Mitomycin C on Hyettrophic scars in comparison with triamcinolone injection in burn patients

Comparison of the effect of Mitomycin C and triamcinolone injection on Hypertrophic scars in burn patients in Ahwaz city

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230212057391N1

Enrollment

Registered

2023-04-10

Start date

2023-02-20

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn. Burn and corrosion of head, face, and neck

Interventions

Intervention 1: Intervention group: recipient of mitomycin C with a concentration of .4 mg/d, one dose, manufactured by KOREA UNITED PHARM. Intervention 2: Control group: Control group: triamcilonone,

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with burns and needing injections Patients over 18 years old

Exclusion criteria

Exclusion criteria: • Pregnant women and nursing mothers • People with mental problems • Inability to write or read Farsi • Prisoners • People who do not want to participate in the study

Design outcomes

Primary

Measure	Time frame
Hypertrophic scars. Timepoint: In a period of 2 months at the beginning of the study and 2 months after the injection. Method of measurement: Measurement is done with a ruler.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdulreza Sheikhi

Ahvaz University of Medical Sciences

sheikhi-a@ajums.ac.ir009861337430011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026